Stance Capital’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
VCM
GKFF
GS
RHJA
Stance Capital's ASPN Position: Q1 2026 in Review
Stance Capital opened a new position in Aspen Aerogels (ASPN) in Q1 2026: 811 shares worth $2.77K. The stake represents ﹤0.01% of the portfolio and ranks #270 among its holdings. This is a return to the name: Stance Capital previously reported a position in ASPN as recently as Q3 2025.
Stance Capital first reported a position in ASPN in Q4 2024 and has held it in 3 quarters since. The position peaked at $34.3K in Q4 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.
- Stance Capital held 811 shares of Aspen Aerogels worth $2.77K as of Q1 2026.
- Aspen Aerogels was a new Stance Capital position in Q1 2026.
- Aspen Aerogels made up ﹤0.01% of Stance Capital's portfolio in Q1 2026, its #270 holding.
- Stance Capital first reported a position in Aspen Aerogels in Q4 2024 and has held it in 3 quarters since.
- Stance Capital's Aspen Aerogels position peaked at $34.3K in Q4 2024.
- 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.
Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.